Clinical significance of the emergence of bacterial resistance in the hospital environment

Journal of Applied Microbiology Symposium Supplement

Volumn 92, Issue 1, 2002, Pages

  Hosein, I K ^a,b   Hill, D W ^a   Jenkins, L E ^a   Magee, J T ^a  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN; CHLORAMPHENICOL; GENTAMICIN; NITROFURANTOIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; SPECTINOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG COST; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; GENERAL PRACTICE; HOSPITAL; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INTESTINE; LOBAR PNEUMONIA; LUNG TUBERCULOSIS; MORBIDITY; MORTALITY; NONHUMAN; PNEUMONIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; BACTERIUM; CROSS INFECTION; GENETICS; HYGIENE; PATHOGENICITY; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INFECTION CONTROL; BACTERIA; HYGIENE;

ACINETOBACTER; ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0036096610     PISSN: 02674440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Antibiotic resistance of Escherichia coli isolated from poultry workers, patients and chicken in the eastern province of Saudi Arabia
2. Cost-effectiveness of pneumococcal vaccination of older people: A study in 5 Western European countries
3. Therapy for children for invasive pneumococcal infections
4. Antibiotic resistance in Spain: What can be done?
5. The impact of antibiotic use on resistance development and persistence
6. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics
7. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999
8. Use of linezolid, an oxazolidinone, in the treatment of multi-drug resistant gram-positive bacterial infections
9. Treatment failure in otitis media: An analysis
10. A major outbreak of methicillin resistant Staphylococcus aureus caused by a new phage type (EMRSA-16)
11. Mopping up hospital infection
12. Plasmids of the same Inc groups in enterobacteria before and after the medical use of antibiotics
13. Routine disinfection of patients' environmental surfaces. Myth or reality?
14. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonised patients
15. Role of antimicrobial central venous catheters for the prevention of associated infections
16. Emergence and dissemination of quinolone resistant Escherichia coli in the community
17. Strategies to prevent and control spread of antimicrobial-resistant micro-organisms - A challenge to hospital leadership
18. Antibiotic resistance in Gram-negative bacteria: The role of gene cassettes and integrons
19. Current challenges in antibiotic resistance
20. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk
21. Health and economic impacts of anti-microbial resistance
22. Seventh report
23. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: Case report and review
24. The microbial genetics of antibiotic cycling
25. Prevalence of antibiotic resistance in pneumococci in England and Wales: Results of observational surveys in 1990 and 1995
26. Adverse effects of contact isolation
27. Enterococcus faecium strains with van-A mediated high-level glycopeptide resistance isolated from animal foodstuffs and faecal samples of humans in the community
28. The experience of infectious patients in isolation
29. How do we choose antibiotic treatment?
30. Influence of prescription patterns in general practice on antimicrobial resistance in Norway
31. Antibiotic prescribing and resistance in the community
32. Multi-drug resistant tuberculosis and HIV: A personal experience
33. Complicated UTI: Effective treatment in the long-term care setting
34. A novel anti-microbial agent joins the battle against resistant bacteria
35. Quinpristin/dalfopristin: Theraputic potential for vancomycin resistant enterococcal infections
36. Resistance to methicillin in isolates of Staphylococcus aureus from blood and cerebrospinal fluid in Wales 1993-1997
37. The toilet as a transmission vector of vancomycin-resistant enterococci
38. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California
39. Managing and maintaining a safe environment in the hospital
40. Outbreak of nosocomial multi-drug resistant Enterobacter aerogenes in a geriatric unit: Failure of isolation, analysis of risk factors, and use of pulsed-field gel electropharesis
41. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
42. First clinical isolate of vancomycin-intermediate Staphlococcus aureus in a French hospital
43. Clostridium difficile and vancomycin-resistant enterococci - The new nosocomial alliance
44. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis
45. Infectious diseases and litigation
46. Clinical governance and the drive for quality improvement in the new NHS in England
47. Multi resistant Escherichia coli from elderly patients
48. Emerging health care-associated infections in the geriatric population
49. Methicillin-resistant Staphylococcus aureus in a nursing home and affiliated hospital: A four year perspective
50. The role of the hospital environment in the epidemiology of multi resistant bacteria
51. Increasing incidence of resistance to trimethoprim and ciprofloxacin in endemic Salmonella typhimurium DT104 in England and Wales
52. Penicillin resistance and other predictors of mortality in pneumococcal bacteraemia in a population with high human immunodeficiency virus seroprevalence
53. Surveillance of resistance against antimicrobial agents: A European perspective
54. Nosocomial infections in the ICU: The growing importance of antibiotic resistant pathogens
55. Microbial quality of ice in hospitals and community